Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.084
Sell
RSI(14)
36.552
Neutral
STOCH(KDJ)(9,3,3)
18.169
Neutral
ATR(14)
0.248
Low Volatility
CCI(14)
-82.041
Neutral
Williams %R
90.550
Oversold
TRIX(12,20)
-1.330
Sell
StochRSI(14)
88.012
Buy
Search
Lantern Pharma Inc
LTRNAdd to Watchlist
2.630USD
-0.020-0.75%
Close 07-31 16:00（ET）Quotes delayed by 15 min
29.60MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.75%
5 Days
-4.36%
1 Month
-36.93%
6 Months
-16.51%
Year to Date
-13.20%
1 Year
-40.77%
Key Figures
2.720Open
2.870High
47.91KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.43%Turnover Ratio
2.650Prev. Close
2.570Low
69.19KTurnover
LossP/E Static
8.59P/B
0.00%Div Yield TTM
-112.37%ROA
5.74452wk High
0.90Volume Ratio
-20.78MNet Profit
11.25MShares
-1.4460EPS TTM
2.27Beta
-157.37%ROE
1.11052wk Low
11.32%Amplitude
--Gross Margin
29.60MMarket Cap
-5.35Reward/Risk
6.09%Risk Rate
Lantern Pharma Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
25.000
Target Price
+896.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Lantern Pharma Inc
LTRN
1
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
2.636
Sell
MA10
2.753
Sell
MA20
3.024
Sell
MA50
3.452
Sell
MA100
2.844
Sell
MA200
3.099
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Lantern Pharma Inc Info
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Ticker SymbolLTRN
CompanyLantern Pharma Inc
CEOSharma (Panna L)
Websitehttps://www.lanternpharma.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Lantern Pharma Inc (LTRN)?
The current price of Lantern Pharma Inc (LTRN) is 2.61.
What is the symbol of Lantern Pharma Inc?
The ticker symbol of Lantern Pharma Inc is LTRN.
What is the 52-week high of Lantern Pharma Inc?
The 52-week high of Lantern Pharma Inc is 5.74.
What is the 52-week low of Lantern Pharma Inc?
The 52-week low of Lantern Pharma Inc is 1.11.
What is the market capitalization of Lantern Pharma Inc?
The market capitalization of Lantern Pharma Inc is 29.42M.
Is Lantern Pharma Inc (LTRN) currently rated as Buy, Hold, or Sell?
According to analysts, Lantern Pharma Inc (LTRN) has an overall rating of Buy, with a price target of 25.00.
What is the Earnings Per Share (EPS TTM) of Lantern Pharma Inc (LTRN)?
The Earnings Per Share (EPS TTM) of Lantern Pharma Inc (LTRN) is -1.57.